|
Please confirm that the title of the tutorial
|
Personal information
Name:
Street Address:
Street Address:
City, State, Zip Code:
VOICE #:
Special
Needs:
E-mail Address:
Work telephone #:
Work FAX # :
TEST: PET Radiopharmaceuticals
|
1. What Does PET stand for?: Positive Effective Therapy Proton Emission Tomography Positron Effective Therapy None
of the Above |
|
2. Which ONE of the following isotopes can NOT be used for Coincidence Imaging?: Co-57 C-11 O-15 N-13 |
|
3. Which ONE of the following series contains ONLY positron emitters?: Rb-82, F-18,Co-57 N-13, F-18, Co-57 C-11, N-13, Rb-82 I-123,
I-125, I-131 |
|
4. Which ONE of the following oncologic indications has NOT been approved by Medicare for reimbursement?: Testicular Carcinoma Ovarian Cancer Lymphoma Colorectal
Cancer |
|
5. What is the method of localization of FDG in malignant tumors?: Metabolic Trapping Receptor Binding Metabolic Interpolation Glucose
Intolerance |
|
6. What is the most commonly used PET Radiopharmaceutical worldwide?: F-18 FDG C-11 Labeled Co2 N-13 Ammonia O-15
H2O |
|
7. Which Statement is Correct?: FDG is the only F-18 compound ever synthesized for nuclear medicine usage. F-18 has synthesized several compounds for use in nuclear medicine. N-13 Ammonia has a better half life than F-18 for clinical nuclear medicine usage. Rb-82
has never been used for PET imaging. |
|
8. The Half Life of F-18 is?: 118 minutes 18 minutes 110 minutes 2.04
minutes |
|
9. For which of the following conditions does PET have great diagnostic value?: Metastatic Disease Differentiating Necrosis From Tumor Primary Tumors All
of the Above |
|
10. Which is a correct statement about PET pharmaceuticals?: It must alter the process it is trying to image. It must avoid any metabolic interaction. It must ensure metabolic changes to the target organ. It must not alter the process it is trying to image. |
 | |
|
